NCT02095860View on ClinicalTrials.gov

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

DCV 3DAA FDC

Fixed Dose Combination of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325

Trial Locations (1)

78209

Healthcare Discoveries, Llc D/B/A Icon Development Solutions, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY